Pay in 4 interest-free payments of $6.97 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
Ozempic (semaglutide) : approved for type 2 diabetes Wegovy (semaglutide) : approved for chronic weight management in adults with obesity (BMI 30) or overweight (BMI 27) with weight-related comorbidities Mounjaro (tirzepatide) : approved for type 2 diabetes Zepbound (tirzepatide) : approved for chronic weight management under the same criteria as Wegovy If you dont have diabetes, the weight-management brands (Wegovy, Zepbound) are what your doctor would prescribe, assuming you meet the criteria
and the Japanese Governments Ministry of Education, Culture, Sports, Science and Technology Scholarship (Monbukagakusho: MEXT) for doctoral fellowship
We are not just a Med-Spa
GLP-1 can potentially reduce the total medication burden: Metformin: May become unnecessary as glucose normalizes discuss with your doctor Blood pressure medications: As BP drops, your doctor may reduce or eliminate antihypertensives Statins: Lipid improvements may allow dose reduction (never self-discontinue) Sleep apnea treatment: CPAP dependency may decrease see our sleep guide Important: Never stop or reduce any medication without explicit clinician guidance
US$ 20.06
US$ 23.19
US$ 25.17
US$ 28.30
US$ 28.89
US$ 21.07
US$ 23.05
US$ 29.30
US$ 19.99
US$ 20.89
